Status:
RECRUITING
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
Lead Sponsor:
HJN Sverige AB/Neko Health
Conditions:
Coronary Arterial Disease (CAD)
Arterial Stiffness
Eligibility:
All Genders
58-72 years
Brief Summary
This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and pulse wave characteristics and explore its potential in assessment of coronary artery dise...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death globally, placing a large burden on the healthcare system. In asymptomatic individuals, there exists several risk scores to predict cardiova...
Eligibility Criteria
Inclusion
- Subjects already included in the main / general SCAPIS 2 study at Danderyd Hospital in Stockholm, and of which has also participated in the echocardiography examination
Exclusion
- Patients unable to provide an informed consent
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT07001007
Start Date
July 1 2024
End Date
June 1 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danderyds Hospital, KFC - Hjärt-kärllaboratoriet
Stockholm, Sweden